ESLOY:OTO-Compagnie Generale d'Optique Essilor International ADR (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 107.282

Change

-1.68 (-1.54)%

Market Cap

USD 24.84B

Volume

0.02M

Analyst Target

USD 54.27
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Essilor International SA designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures, purchases and sales frames, sunglasses, protective lenses and other protective equipment.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-0.67 (-0.28%)

USD 68.58B
ALC Alcon AG

-0.91 (-1.01%)

USD 44.20B
HYB New America High Income Closed..

-0.03 (-0.41%)

USD 35.93B
RMD ResMed Inc

-0.66 (-0.30%)

USD 31.27B
WST West Pharmaceutical Services I..

+2.59 (+0.74%)

USD 26.66B
BAX Baxter International Inc

-0.26 (-0.73%)

USD 18.05B
ATR AptarGroup Inc

+0.26 (+0.18%)

USD 9.76B
TFX Teleflex Incorporated

-1.22 (-0.56%)

USD 9.61B
STVN Stevanato Group SpA

+0.39 (+1.90%)

USD 5.95B
BLCO Bausch + Lomb Corp

+0.25 (+1.67%)

USD 5.27B

ETFs Containing ESLOY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.76% 79% B- 72% C
Dividend Return 2.10% 100% F 77% C+
Total Return 8.86% 79% B- 76% C+
Trailing 12 Months  
Capital Gain 5.59% 63% D 48% F
Dividend Return 3.82% 80% B- 56% F
Total Return 9.41% 74% C 48% F
Trailing 5 Years  
Capital Gain 79.82% 75% C 85% B
Dividend Return 12.92% 88% B+ 52% F
Total Return 92.74% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 11.35% 63% D 73% C
Dividend Return 12.71% 74% C 72% C
Total Return 1.36% 60% D- 33% F
Risk Return Profile  
Volatility (Standard Deviation) 21.97% 68% D+ 52% F
Risk Adjusted Return 57.85% 95% A 81% B-
Market Capitalization 24.84B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.